Dr. Marie Bleakley

For the Media

Dr. Marie Bleakley

Dr.Marie Bleakley is an associate member of Fred Hutch's Clinical Research Division and a member of the Program in Immunology. She is a pediatric oncologist with expertise in hematopoietic (blood-forming) stem cell transplantation (HCT) to treat leukemia. Her research is focused on improving outcomes for patients with high-risk leukemia by developing new strategies that optimize the activities of T cells in the context of hemapoietic transplantation.

Resources for more information

  • Overview of Marie Bleakley’s Research Focus
    She is working to promote the advantageous Graft-Versus-Leukemia (GVL) effect and reduce the potentially dangerous GVHD that also can be caused by donor T cells after allogeneic transplantation.
  • Marie Bleakley – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
  • The Bleakley Lab
    The lab has extensive expertise in the isolation, culture, genetic modification, and propagation of antigen-specific T cells, in bioinformatics, genetic and molecular techniques employed for antigen discovery, and in flow cytometry and functional analysis of human T cells for correlative studies of human immunotherapy and HCT clinical trials.
  • Program in Immunology
    Program researchers continue to develop ways to make immunity-boosting therapies even more effective. They are showing these treatments can induce remissions for patients with advanced tumors and are likely to have broad utility across many cancers. 


Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


Photos / Graphics / Video


Download photos and view a video of Marie Bleakley

Related Stories

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.